University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Blood Cancer J. 2019 Feb 26;9(3):25. doi: 10.1038/s41408-019-0186-8.
Abnormal serum immunoglobulin (Ig) free light chains (FLC) are established biomarkers of early disease in multiple B-cell lymphoid malignancies, including chronic lymphocytic leukemia (CLL). Heavy chains have also been shown to be biomarkers in plasma cell disorders. An unanswered question is whether these Ig biomarkers are heritable, i.e., influenced by germline factors. CLL is heritable but highly heterogeneous. Heritable biomarkers could elucidate steps of disease pathogenesis that are affected by germline factors, and may help partition heterogeneity and identify genetic pleiotropies across malignancies. Relatives in CLL pedigrees present an opportunity to identify heritable biomarkers. We compared FLCs and heavy chains between relatives in 23 high-risk CLL pedigrees and population controls. Elevated IgM (eIgM) and abnormal FLC (aFLC) ratio was significantly increased in relatives, suggesting that these Ig biomarkers are heritable and could offer risk stratification in pedigree relatives. Within high-risk CLL pedigrees, B-cell lymphoid malignancies were five times more prevalent in close relatives of individuals with eIgM, prostate cancer was three times more prevalent in relatives of individuals with aFLC, and monoclonal B-cell lymphocytosis increased surrounding individuals with normal Ig levels. These different clustering patterns suggest Ig biomarkers have the potential to partition genetic heterogeneity in CLL and provide insight into distinct heritable pleiotropies associated with CLL.
异常血清免疫球蛋白(Ig)游离轻链(FLC)是多种 B 细胞淋巴恶性肿瘤(包括慢性淋巴细胞白血病[CLL])早期疾病的既定生物标志物。重链也已被证明是浆细胞疾病的生物标志物。一个悬而未决的问题是这些 Ig 生物标志物是否具有遗传性,即受种系因素影响。CLL 是遗传性的,但高度异质性。遗传性生物标志物可以阐明受种系因素影响的疾病发病机制步骤,并可能有助于划分异质性并识别恶性肿瘤之间的遗传多效性。CLL 家系中的亲属为识别遗传性生物标志物提供了机会。我们比较了 23 个高危 CLL 家系和人群对照中亲属之间的 FLC 和重链。亲属中的 IgM 升高(eIgM)和异常 FLC(aFLC)比值显著增加,这表明这些 Ig 生物标志物是遗传性的,可在亲属中进行风险分层。在高危 CLL 家系中,eIgM 个体的近亲中 B 细胞淋巴恶性肿瘤的患病率增加了五倍,aFLC 个体的近亲中前列腺癌的患病率增加了三倍,正常 Ig 水平个体的周围出现了单克隆 B 细胞淋巴增生症。这些不同的聚类模式表明,Ig 生物标志物有可能划分 CLL 中的遗传异质性,并深入了解与 CLL 相关的独特遗传多效性。